Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt progression of transient neonatal diabetes mellitus, with complete remission within 6 months. On the second day of life, the patient presented with tachypnea, hyperglycemia, and decreased serum levels of C-peptide and insulin. Continuous subcutaneous infusion of insulin and continuous glucose monitoring were well tolerated. The patient showed a normal growth pattern, with no hyperglycemic or hypoglycemic episodes at 6 months of age. As it is rare and often asymptomatic, hyperglycemia may be attributed to various factors, including intrauterine environment, perinatal stress, and diverse genetic background. Therefore, consistent blood glucose monitoring and prompt early insulin therapy are crucial for any term newborns with persistent hyperglycemia, to prevent further diabetic complications. Moreover, continuous subcutaneous insulin infusion and the utilization of continuous glucose monitoring devices are the most effective and practical management strategies.
Abstract
Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt progression of transient neonatal diabetes mellitus, with complete remission within 6 months. On the second day of life, the patient presented with tachypnea, hyperglycemia, and decreased serum levels of C-peptide and insulin. Continuous subcutaneous infusion of insulin and continuous glucose monitoring were well tolerated. The patient showed a normal growth pattern, with no hyperglycemic or hypoglycemic episodes at 6 months of age. As it is rare and often asymptomatic, hyperglycemia may be attributed to various factors, including intrauterine environment, perinatal stress, and diverse genetic background. Therefore, consistent blood glucose monitoring and prompt early insulin therapy are crucial for any term newborns with persistent hyperglycemia, to prevent further diabetic complications. Moreover, continuous subcutaneous insulin infusion and the utilization of continuous glucose monitoring devices are the most effective and practical management strategies.
참고문헌 (24)
- Lemelman MB, "Neonatal diabetes mellitus : an update on diagnosis and management", Clin Perinatol, 45, pp.41~59 (2018)
- Sahebi L, "Iranian neonatal diabetes mellitus due to mutation in PDX1gene : a case report", J Med Case Rep, 13, pp.258~ (2019)
- Touati A, "Transient neonatal diabetes mellitus and hypomethylation at additional imprinted loci : novel ZFP57mutation and review on the literature", Acta Diabetol, 56, pp.301~307 (2019)
- Huang K, "Permanent neonatal diabetes mellitus in China", BMC Pediatr, 14, pp.188~ (2014)
- 임정섭, "New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008–2012)", Annals of Pediatric Endocrinology & Metabolism, 19(3), pp.146~153 (2014), 대한소아내분비학회
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Simsek DG, "Neonatal hyperglycemia, which threshold value, diagnostic approach and treatment? : Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report", Turk Pediatri Ars, 53, pp.S234~S238 (2018)
- Hay WW Jr, "Neonatal hyperglycemia-causes, treatments, and cautions", J Pediatr, 200, pp.6~8 (2018)
- Suzuki S, "Evaluation of glycated hemoglobin and fetal hemoglobinadjusted HbA1c measurements in infants", Pediatr Diabetes, 14, pp.267~272 (2013)
- Kurnaz E, "Conventional insulin pump therapy in two neonatal diabetes patients harboring the homozygous PTF1A enhancer mutation: need for a novel approach for the management of neonatal diabetes", Turk J Pediatr, 59, pp.458~462 (2017)
- Shah R, "Neonatal hypoglycemia : continuous glucose monitoring", Curr Opin Pediatr, 30, pp.204~208 (2018)
- Cao B, "Genetic analysis and follow-up of 25 neonatal diabetes mellitus patients in China", J Diabetes Res, 2016, pp.6314368~ (2016)
- Naylor RN, "Genetics and pathophysiology of neonatal diabetes mellitus", J Diabetes Investig, 2, pp.158~169 (2011)
- Loomba-Albrecht LA, "An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus", Clin Ther, 31, pp.816~820 (2009)
- Fu JL, "Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea", Chin Med J(Engl), 132, pp.846~848 (2019)
- Barbetti F, "Genetic causes and treatment of neonatal diabetes and early childhood diabetes", Best Pract Res Clin Endocrinol Metab, 32, pp.575~591 (2018)
- Aguilar-Bryan L, "Neonatal diabetes mellitus", Endocr Rev, 29, pp.265~291 (2008)
- Rubio-Cabezas O, "Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options", Horm Res Paediatr, 80, pp.137~146 (2013)
- Asl SN, "Wolcott-Rallison syndrome in Iran : a common cause of neonatal diabetes", J Pediatr Endocrinol Metab, 32, pp.607~613 (2019)
- Evliyaoglu O, "Neonatal diabetes: two cases with isolated pancreas agenesis due to homozygous PTF1A enhancer mutations and one with developmental delay, epilepsy, and neonatal diabetes syndrome due to KCNJ11 mutation", J Clin Res Pediatr Endocrinol, 10, pp.168~174 (2018)
- Berg JS, "Exploring the importance of case-level clinical information for variant interpretation", Genet Med, 19, pp.3~5 (2017)
- Shah RP, "Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas", Diabetes Care, 35, pp.2086~2088 (2012)
- Svalastoga P, "Intellectual disability in KATP channel neonatal diabetes", Diabetes Care, 43, pp.526~533 (2020)
- Li X, "Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up : experience from China", Pediatr Diabetes, 19, pp.251~258 (2018)